| CPC A61K 47/26 (2013.01) [A61K 9/00 (2013.01); A61K 9/0021 (2013.01); A61K 9/70 (2013.01); A61K 9/7007 (2013.01); A61M 37/00 (2013.01); A61M 37/0015 (2013.01); B29C 39/026 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); B29K 2089/00 (2013.01); B29L 2031/7544 (2013.01); B29L 2031/756 (2013.01)] | 11 Claims |

|
1. A nucleic acid film-based drug administration device, comprising:
a nucleic acid film consisting of a nucleic acid alone, the nucleic acid film configured to contact human skin;
a finishing film stacked on the nucleic acid film; and
a drug filling a first space between the nucleic acid film and the finishing film,
wherein a microneedle or a drug delivery portion protrudes from one surface of the nucleic acid film towards the human skin.
|